Literature DB >> 34566305

Posterior Reversible Encephalopathy Syndrome: Nitroglycerine a Friend or a Foe?

Sairem Mangolnganbi Chanu1, B C Priyanka1, Dasari Papa1, Samarjit Dey2.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) refers to a clinico-radiological entity with characteristic features on neuroimaging and rapid onset of nonspecific symptoms including headache, seizure, altered consciousness and visual disturbance. It is a neurotoxic state in response to the acute changes in blood pressure leading to vasogenic oedema. It is often but not always associated with hypertension. However, control blood pressure is one of the mainstays of management in such cases. Nitroglycerine (NTG) is a potent vasodilator and is one of the drugs for treatment of hypertensive emergencies. It is found to worsen the cerebral oedema in PRES which is considered due to failure of cerebral blood pressure autoregulation. Here, we report two such cases where patients with PRES deteriorated with NTG infusion. However, the neurological condition of the patients improved drastically the next day. NTG could have further enhanced vasodilation, thus aggravating developing PRES, after autoregulation was lost because of high blood pressure. © Federation of Obstetric & Gynecological Societies of India 2021.

Entities:  

Keywords:  Eclampsia; Nitroglycerine; Posterior reversible encephalopathy syndrome; Pre-eclampsia

Year:  2021        PMID: 34566305      PMCID: PMC8418574          DOI: 10.1007/s13224-020-01411-8

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  3 in total

1.  Nitroglycerin-aggravated pre-eclamptic posterior reversible encephalopathy syndrome (PRES).

Authors:  J Finsterer; T Schlager; W Kopsa; E Wild
Journal:  Neurology       Date:  2003-09-09       Impact factor: 9.910

2.  Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients.

Authors:  Giuseppe Servillo; Pasquale Striano; Salvatore Striano; Fabio Tortora; Patrizia Boccella; Edoardo De Robertis; Flavia Rossano; Francesco Briganti; Rosalba Tufano
Journal:  Intensive Care Med       Date:  2003-08-06       Impact factor: 17.440

3.  Management of posterior reversible syndrome in preeclamptic women.

Authors:  S Poma; M P Delmonte; C Gigliuto; R Imberti; M Delmonte; A Arossa; G A Iotti
Journal:  Case Rep Obstet Gynecol       Date:  2014-11-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.